These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 35308057)
1. Cases of catastrophic anti-phospholipid syndrome in systemic lupus erythematosus: An experience. Hegde A; Dorji T; Asturkar V; Yangzom S; Bhanu KU SAGE Open Med Case Rep; 2022; 10():2050313X221085099. PubMed ID: 35308057 [TBL] [Abstract][Full Text] [Related]
2. Catastrophic Anti-Phospholipid Syndrome in Systemic Lupus Erythematosus: A Tsunami in the Ocean. Dorji T; Hegde A; Asturkar V; Yangzom S; Bhanu K J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443434 [TBL] [Abstract][Full Text] [Related]
3. [Case series and clinical analysis of 14 cases of catastrophic antiphospholipid syndrome]. Gu JY; Lu C; Shi H; Yang CD Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1033-1038. PubMed ID: 30562777 [TBL] [Abstract][Full Text] [Related]
5. A Simplified Understanding of the Black Swan: Anti-phospholipid Antibody Syndrome. Vaidya B; Nakarmi S; Joshi R; Baral R JNMA J Nepal Med Assoc; 2019; 57(216):133-145. PubMed ID: 31477950 [TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual. Frodlund M; Vikerfors A; Grosso G; Skogh T; Wetterö J; Elvin K; Gunnarsson I; Kastbom A; Dahlström Ö; Rönnelid J; Svenungsson E; Sjöwall C Clin Exp Immunol; 2018 Oct; 194(1):27-38. PubMed ID: 30208508 [TBL] [Abstract][Full Text] [Related]
7. Coagulation tests and anti-phospholipid antibodies in patients positive for lupus anticoagulant. Sakakura M; Wada H; Watanabe R; Mamamuro M; Okugawa Y; Nakasaki T; Nakase T; Wakita Y; Minamikawa K; Mori Y; Nshikawa M; Shiku H Clin Appl Thromb Hemost; 2000 Jul; 6(3):144-50. PubMed ID: 10898274 [TBL] [Abstract][Full Text] [Related]
8. Antibodies to age-β2 glycoprotein I in patients with anti-phospholipid antibody syndrome. Sorice M; Buttari B; Capozzi A; Profumo E; Facchiano F; Truglia S; Recalchi S; Alessandri C; Conti F; Misasi R; Valesini G; Riganò R Clin Exp Immunol; 2016 May; 184(2):174-82. PubMed ID: 26702877 [TBL] [Abstract][Full Text] [Related]
9. A novel ELISA system for simultaneous detection of six subclasses of anti-phospholipid antibodies for prediction of thrombotic complications among SLE patients. Nojima J; Motoki Y; Aoki N; Tsuneoka H; Ichihara K Thromb Res; 2014 Jun; 133(6):1135-40. PubMed ID: 24721837 [TBL] [Abstract][Full Text] [Related]
10. Antiphospholipid syndrome - an update. Linnemann B Vasa; 2018 Oct; 47(6):451-464. PubMed ID: 30205764 [TBL] [Abstract][Full Text] [Related]
11. A catastrophic seronegative anti-phospholipid syndrome: case and literature review. Pinto V; Ministro A; Carreira NR; Cardoso A; Gonçalves CS; Henriques M; Rato J; Silva E; Pedro LM Thromb J; 2021 Dec; 19(1):103. PubMed ID: 34930339 [TBL] [Abstract][Full Text] [Related]
12. [Advanced clinical laboratory studies in the graduate school of medicine--studies on pathogenic mechanisms of anti-phospholipid syndrome]. Nojima J Rinsho Byori; 2009 Aug; 57(8):786-92. PubMed ID: 19764414 [TBL] [Abstract][Full Text] [Related]
13. PP068. Catastrophic antiphospholipid-syndrome (CAPS) - A severe pregnancy complication. Schlembach D; Mayer-Pickel KI; Cervar-Zivkovic M; Moertl MG; Lang U; Schleussner E Pregnancy Hypertens; 2012 Jul; 2(3):278. PubMed ID: 26105390 [TBL] [Abstract][Full Text] [Related]
14. Update on anti-phospholipid antibodies in SLE: the Hopkins' Lupus Cohort. Petri M Lupus; 2010 Apr; 19(4):419-23. PubMed ID: 20353980 [TBL] [Abstract][Full Text] [Related]
15. Abnormal immunothrombosis and lupus anticoagulant in a catastrophic COVID-19 recalling Asherson's syndrome. Roncati L; Corsi L; Barbolini G J Thromb Thrombolysis; 2021 Nov; 52(4):1043-1046. PubMed ID: 33844151 [TBL] [Abstract][Full Text] [Related]
16. Extensive vascular occlusions as initial presentations of systemic lupus erythematosis. A case report and review of literature. Elsharawy M; Hasan M; Abdul-Rahman IS; Al-Dhofairy B; Elsaid A Avicenna J Med; 2015; 5(2):42-5. PubMed ID: 25878966 [TBL] [Abstract][Full Text] [Related]
17. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome. Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458 [TBL] [Abstract][Full Text] [Related]
18. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus. Danowski A; de Azevedo MN; de Souza Papi JA; Petri M J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935 [TBL] [Abstract][Full Text] [Related]
19. Catastrophic anti-phospholipid syndrome in the absence of IgG anti-cardiolipin antibodies. Kennedy M; Jackson J; Khan I; Keeling PW; Gaffney E Scand J Rheumatol; 1995; 24(6):389-91. PubMed ID: 8610226 [TBL] [Abstract][Full Text] [Related]
20. Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis. Reynaud Q; Lega JC; Mismetti P; Chapelle C; Wahl D; Cathébras P; Laporte S Autoimmun Rev; 2014 Jun; 13(6):595-608. PubMed ID: 24418303 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]